HF
IMVT icon

HRT Financial’s Immunovant IMVT Stock Holding History

HRT Financial’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Buy
331,920
+265,435
+399% +$8.09M 0.02% 665
2026
Q1 		$1.65M Sell
66,485
-18,355
-22% -$475K ﹤0.01% 1741
2025
Q4 		$2.16M Buy
+84,840
New +$1.89M 0.01% 1253
2024
Q1 		– Sell
-92,731
Closed -$3.91M – 2657
2023
Q4 		$3.91M Buy
+92,731
New +$3.41M 0.03% 387
2022
Q4 		– Sell
-143,690
Closed -$801K – 2776
2022
Q3 		$801K Buy
+143,690
New +$702K 0.01% 1070
2022
Q2 		– Sell
-92,945
Closed -$512K – 3279
2022
Q1 		$512K Buy
92,945
+2,066
+2% +$12.9K ﹤0.01% 1619
2021
Q4 		$774K Sell
90,879
-153,002
-63% -$1.26M ﹤0.01% 1344
2021
Q3 		$2.12M Buy
243,881
+65,037
+36% +$587K 0.01% 695
2021
Q2 		$1.89M Buy
+178,844
New +$2.5M 0.02% 654

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's IMVT Position: Q2 2026 in Review

HRT Financial increased its Immunovant (IMVT) stake by 399% in Q2 2026, buying an estimated $8.09M and bringing the position to 331,920 shares worth $12.8M. The position accounts for 0.02% of the portfolio, ranked #665.

HRT Financial first reported a position in IMVT in Q2 2021 and has held it in 9 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • HRT Financial held 331,920 shares of Immunovant worth $12.8M as of Q2 2026.
  • HRT Financial bought 265,435 Immunovant shares in Q2 2026, an estimated $8.09M.
  • Immunovant made up 0.02% of HRT Financial's portfolio in Q2 2026, its #665 holding.
  • HRT Financial first reported a position in Immunovant in Q2 2021 and has held it in 9 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.